Autopsy report · NCT02161016

A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3® Cellular Allogeneic Bone Graft

“slow recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 7 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

RTI Surgical

Sponsor type

Industry

Conditions

Foot Deformities, Acquired; Disorder of Joint of Foot; Fracture of Foot; Deformity of Bone

Interventions

map3

Participants

1

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.